News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|February 27, 2008

Humira approved for juvenile rheumatoid arthritis

Abbott's Humira (adalimumab) had been approved by the food and Drug Administration for its sixth indication, juvenile rheumatoid arthritis...

Abbott's Humira (adalimumab) has been approved by the Food and Drug Administration for its sixth indication, juvenile rheumatoid arthritis.

JVA joins other indications including chronic plaque psoriasis, rheumatoid arthritis in adults, and Crohn's disease.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Joel Stoddard, MD, on youth suicide, firearm access, and universal screening in prevention

ByJoel Stoddard, MD, MAS

January 30th 2026

Low Apgar score, cord pH linked to ADHD risk | Image Credit: © BazziBa - © BazziBa - stock.adobe.com.

Low Apgar score, cord pH linked to ADHD risk

ByCeleste Krewson, Assistant Editor

January 30th 2026

Jeffrey Segar, MD, highlights sodium supplementation to support infant weight gain | Image Credit: childrenswi.org.

Jeffrey Segar, MD, highlights sodium supplementation to support infant weight gain

ByJeffrey L. Segar, MD

January 30th 2026

AAP issues guidance on providing medical care to parents during pediatric visits | Image Credit: © N Lawrenson/peopleimages.com - stock.adobe.com.

AAP issues guidance on providing medical care to parents during pediatric visits

ByMorgan Ebert, Managing Editor

January 30th 2026

AAP calls for system-level changes to improve children’s digital media environments | Image Credit: © peopleimages.com - stock.adobe.com.

AAP calls for system-level changes to improve children’s digital media environments

ByMorgan Ebert, Managing Editor

January 29th 2026

Latest CME

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Trending on Contemporary Pediatrics

Genomic sequencing may transform newborn screening

Kathryn M. Stephenson, MD, MA, discusses GLP-1 RA decisions for pediatric obesity

AAP calls for system-level changes to improve children’s digital media environments

AAP updates guidance on therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy

AAP publishes 2026 childhood and adolescent immunization schedule